日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical Characteristics, Treatment Patterns, and Outcomes of Patients With Locally Advanced/Metastatic Hepatocellular Carcinoma Treated at the Veterans Health Administration

退伍军人健康管理局治疗的局部晚期/转移性肝细胞癌患者的临床特征、治疗模式和预后

Alkadimi, Munaf A; Aldawoodi, Tamarah A; Lucero, Kana T; Fierro, Maria E; Boyle, Lauren D; Mader, Michael J; Franklin, Kathleen R; Arora, Sukeshi P; Nooruddin, Zohra

Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration

美国退伍军人健康管理局接受度伐利尤单抗治疗的不可切除III期非小细胞肺癌患者的健康公平性

Moore, Amanda M; Nooruddin, Zohra; Reveles, Kelly R; Koeller, Jim M; Whitehead, Jennifer M; Franklin, Kathleen; Datta, Paromita; Alkadimi, Munaf; Brannman, Lance; Cotarla, Ion; Frankart, Andrew J; Mulrooney, Tiernan; Jones, Xavier; Frei, Christopher R

Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study

退伍军人健康管理局 (VHA) 中不可切除的 III 期非小细胞肺癌患者的度伐利尤单抗治疗模式:一项全国性的真实世界研究

Moore, Amanda M; Nooruddin, Zohra; Reveles, Kelly R; Datta, Paromita; Whitehead, Jennifer M; Franklin, Kathleen; Alkadimi, Munaf; Williams, Madison H; Williams, Ryan A; Smith, Sarah; Reichelderfer, Renee; Cotarla, Ion; Brannman, Lance; Frankart, Andrew; Mulrooney, Tiernan; Hsieh, Kristin; Simmons, Daniel J; Jones, Xavier; Frei, Christopher R